On Air Now

Upcoming Shows

Program Schedule »

Tune in to Listen

1590 AM Coldwater, Michigan 95.5 FM Coldwater, Michigan

Weather

Current Conditions(Coldwater,MI 49036)

More Weather »
75° Feels Like: 75°
Wind: N 8 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Partly Cloudy 55°

Tomorrow

Sunny 75°

Thurs Night

Clear 54°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

Another Supernus epilepsy drug gets FDA nod

(Reuters) - Supernus Pharmaceuticals Inc's experimental epilepsy drug Oxtellar XR won marketing approval from the U.S. Food and Drug Administration, the second drug approval for the company since it went public in May.

Oxtellar XR's final marketing approval follows the tentative approval given in late-June to Supernus's Trokendi XR -- a generic epilepsy treatment.

The company plans to launch Oxtellar in the first quarter of 2013.

Rockville, Maryland-based Supernus is developing several other drugs for epilepsy, depression and attention deficit hyperactivity disorder.

Supernus's shares closed at $12.97 on Friday on the Nasdaq.

(Reporting By Pallavi Ail in Bangalore; Editing by Supriya Kurane)

Comments